{"id":"stimus-nng-depo","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Insomnia"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Anxiety"},{"rate":"5-10%","effect":"Nervousness"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL1200973","moleculeType":"Small molecule","molecularWeight":"396.57"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Stimus (NNG-DEPO) is a central nervous system stimulant that increases the levels of dopamine and norepinephrine in the brain, which can help improve focus, attention, and impulse control. It is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.","oneSentence":"Stimus (NNG-DEPO) is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:28.874Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention deficit hyperactivity disorder (ADHD)"},{"name":"Narcolepsy"}]},"trialDetails":[{"nctId":"NCT05636891","phase":"PHASE1","title":"Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis","status":"COMPLETED","sponsor":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","startDate":"2021-09-19","conditions":"Chronic Kidney Disease","enrollment":43},{"nctId":"NCT05585645","phase":"PHASE3","title":"A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD)","status":"COMPLETED","sponsor":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","startDate":"2019-08-08","conditions":"Anemia, Chronic Kidney Disease Requiring Chronic Dialysis","enrollment":214}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Stimus (NNG-DEPO)","genericName":"Stimus (NNG-DEPO)","companyName":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","companyId":"nanogen-pharmaceutical-biotechnology-joint-stock-company","modality":"Biologic","firstApprovalDate":"","aiSummary":"Stimus (NNG-DEPO) is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain. Used for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}